Health care leaders discuss pharmaceutical financing strategies at MIT

October 26, 2016

Patient advocates, payers, industry and academic stakeholders gathered at the Massachusetts Institute of Technology to map out a strategy for designing and piloting innovative financing and reimbursement models for promising, and possibly curative, new medicines. The project, Financing and Reimbursement of Cures in the US (FoCUS) will initially target three urgent medical areas - Curative Gene Therapies, Durable Oncology Treatments and Antibiotics for Multi-Drug Resistant Infections. Working groups will use components of a dynamic design "toolkit" to tailor innovative finance and reimbursement models that address different characteristics of curative therapy types.